ImmunologybioRxivPreprint
Tertiary lymphoid structure as a therapeutic target of Crohns disease: modulation by TNFα blockade
Yoshihiro Nagase, Soh Okano, Asuka Furukawa…·Makoto Kodama
This study shows that TNF inhibitor infliximab reduces tertiary lymphoid structures and alleviates Crohn's disease inflammation by targeting follicular dendritic cells and macrophages.
1 citation